Diabetes is becoming more common as bad lifestyle choices persist over the world. Insulin pens are a widely used method of giving diabetes therapy to patients. Given this, Future Market Insights expects insulin pen sales to reach US$ 30,407 million in 2021.
Insulin Pen Market value is expected to reach US$ 46,906.4 Mn by 2031, growing at a CAGR of 4.4% between 2021 and 2031. Insulin pens for type 2 diabetes patients will account for more than 70% of insulin pen sales by 2031. This category’s demand is predicted to grow at a CAGR of more than 4%.
Insulin pens are used by diabetes patients to avoid problems including cardiovascular diseases that may arise from this lifestyle-based ailment. To overcome problems related to conventional methods of insulin administration, insulin pens make the process easier and faster.
Download Sample Copy: https://www.futuremarketinsights.com/reports/sample/rep-gb-13518
According to the WHO, approximately 1.2 million deaths were caused due to diabetes in 2019 globally. To reduce the number of deaths or sufferings due to diabetes, the development of innovative techniques and products for the treatment and maintenance of diabetes is essential.
Type 2 diabetes cases are common, but it can be prevented or delayed by a healthy diet, consistent physical activity, maintaining a standard body weight and avoiding the use of tobacco. Diabetes can be treated or managed with medicines and regular checking and treatment. Increasing focus on innovative medical products and research are increasingly driving a transition towards insulin pen by diabetes patients.
Leading manufacturers in the insulin pen market are strengthening their market position through collaborations with various health and research organizations. Governments in developed and developing countries are actively taking initiatives to encourage innovative medical products.
Get In Touch With Our Team For 30% Flat Discount: https://www.futuremarketinsights.com/ask-question/rep-gb-13518
For instance, in November 2020, Medtronic introduced CGM integrated smart insulin delivery pen to manage multiple daily dosage insulin injections. Similarly, Insulet expanded its offering of OmipodDASH into additional countries such as Sweden, Finland, Norway, and Denmark.
Key Takeaways from Insulin Pen Services Market Study
- Reusable insulin pens are expected to account for over 49% the global market share by 2031, supported by a growing base of environment and cost-conscious consumers.
- Hospital pharmacies will account for 33.8% of the market share in 2031. The soaring influx of patients for treatment and intensive care support supports growth.
- The U.S. is projected to be the fastest-growing regional market with a CAGR of 5.6% through 2021-2031 owing to the matured healthcare sector of the country.
- The U.K. and Germany are leading markets in Europe, accounting for more than 18% and 25% in 2021.
- China is the largest and fastest growing market in East Asia, exhibiting a 4.7% CAGR through 2031.
- Australia is leading the Oceania market, accounting for more than 85% of insulin pen revenues in 2021.
Who is Winning?
The global insulin pen market is set to expand due to the rising prevalence of type 1 and type 2 diabetes. Leading organizations within the market are set to focus on research and development to offer an early and precise diagnosis of the ailment, besides offering effective patient care.
Request for Customization: https://www.futuremarketinsights.com/customization-available/rep-gb-13518
Some of the leading players in the insulin pen market include but are not limited to NovoNordisk A/S, Sanofi, Eli Lilly, Diamesco Co., Ltd., BigFoot Biomedical, Inc, Medtronic plc, Emperra GmbH E-Health Technologies, YpsoMed AG, and DUKADA Aps.
Insulin Pens Market by Category
By Product Type:
- Reusable Insulin Pen
- Refillable Pens
- Bluetooth Connected Smart Insulin Pen
- USB Connected Smart Insulin Pen
- Cartridge
- Disposable Insulin Pens
- Smart Insulin Pens Caps
- Insulin Pump
By Indication:
- Type 1
- Type 2
Distribution Channel:
- Hospital Pharmacy
- Retail Pharmacy
- Online Sales
- Diabetes Clinic/Center
Region:
- North America
- Latin America
- Europe
- East Asia
- South Asia
- Oceania
- Middle East and Africa (MEA)
Use promo code ->> FMITODAY to get flat 30% discount
Have a Look at Related Research Reports of Healthcare Domain:
- https://techplanet.today/post/insulin-pen-market-is-forecasted-to-surpass-us-469-bn-by-2031
- https://gab.com/Jaydip123/posts/109518352145566190
- https://likefm.org/blog/insulin-pen-market-is-forecasted-to-surpass-us-469-bn-by-2031
- https://adhipatialumni.com/blogs/63008/Insulin-Pen-Market-is-forecasted-to-surpass-US-46-9
- https://anotepad.com/notes/nndqkbpk
About Future Market Insights (FMI)
Future Market Insights (ESOMAR certified market research organization and a member of Greater New York Chamber of Commerce) provides in-depth insights into governing factors elevating the demand in the market. It discloses opportunities that will favor the market growth in various segments on the basis of Source, Application, Sales Channel and End Use over the next 10-years.
Contact:
Future Market Insights, Inc.
Christiana Corporate, 200 Continental Drive,
Suite 401, Newark, Delaware – 19713, USA
T: +1-845-579-5705
For Sales Enquiries: sales@futuremarketinsights.com
Browse All Reports: https://www.futuremarketinsights.com/reports
LinkedIn| Twitter| Blogs